# Nuvation Bio Inc. (NUVB) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Nuvation Bio Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/NUVB/mda/fy2025/): filed 2026-03-02; accession 0001193125-26-085584 (https://www.sec.gov/Archives/edgar/data/1811063/000119312526085584/nuvb-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/NUVB/mda/fy2024/): filed 2025-03-06; accession 0000950170-25-034903 (https://www.sec.gov/Archives/edgar/data/1811063/000095017025034903/nuvb-20241231.htm)
- [FY 2023 MD&A](/company/NUVB/mda/fy2023/): filed 2024-02-29; accession 0000950170-24-023247 (https://www.sec.gov/Archives/edgar/data/1811063/000095017024023247/nuvb-20231231.htm)
- [FY 2022 MD&A](/company/NUVB/mda/fy2022/): filed 2023-03-15; accession 0000950170-23-008180 (https://www.sec.gov/Archives/edgar/data/1811063/000095017023008180/nuvb-20221231.htm)
- [FY 2021 MD&A](/company/NUVB/mda/fy2021/): filed 2022-02-28; accession 0000950170-22-002332 (https://www.sec.gov/Archives/edgar/data/1811063/000095017022002332/nuvb-20211231.htm)

Back to /company/NUVB/